🔍 Intelligence Synthesis JP/EN
Ethics · Regulation · Technology — Pharma Practice Notes

AI and Rare Diseases ── Platforms ── 2026-11-20

A lab rack of sorted sample tubes in two groups; one maroon tube stands raised, beside an empty dashed slot: a candidate found but not yet verified.
What this means, as an image (AI-generated, GPT Image): Kawasaki disease researchers can treat FNDC5 and the drug candidate as hypotheses to test, not as settled findings.Download image (PNG, 2000×800)
1 Platforms papers. Lead: Deciphering mitochondrial dysfunction and circadian rhythm-related pathogenic patterns for the pathogenesis of Kawasaki Disease and corresponding nursing therapeutic enrichment: Evidence from machine learning-driven multi-omics and clinical validation.

Journals covered and how papers are chosen: see the index

Rare-disease diagnosis and drug discovery platforms and AI

← Back to this issue